OWC Pharmaceutical Valuation
| OWCP Stock | USD 0.0001 0.00 0.00% |
OWC Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of OWC Pharmaceutical from examining the company fundamentals such as shares owned by insiders of 11.15 %, and Current Valuation of 49.75 K as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OWC Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of OWC Pharmaceutical is based on 3 months time horizon. Increasing OWC Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
OWC Pharmaceutical's intrinsic value may or may not be the same as its current market price of 0.0001, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.3E-5 | Hype 1.0E-4 | Naive 1.06E-4 |
The intrinsic value of OWC Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OWC Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OWC Pharmaceutical Research helps investors to forecast how OWC pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OWC Pharmaceutical more accurately as focusing exclusively on OWC Pharmaceutical's fundamentals will not take into account other important factors: OWC Pharmaceutical Total Value Analysis
OWC Pharmaceutical Research is now forecasted to have valuation of 49.75 K with market capitalization of 49.75 K, debt of 0, and cash on hands of 1.47 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OWC Pharmaceutical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.75 K | 49.75 K | 0 | 1.47 M |
OWC Pharmaceutical Asset Utilization
One of the ways to look at asset utilization of OWC is to check how much profit was generated for every dollar of assets it reports. OWC Pharmaceutical owns a negative utilization of current and long term assets of -0.64 %, losing $0.006448 for each dollar of current and long term assets held by the company. Unproductive asset utilization implies the company is being less competent with each dollar of current and long term assets it owns. Strictly speaking, asset utilization of OWC Pharmaceutical Research shows how inefficient it operates for each dollar spent on its current and long term assets.OWC Pharmaceutical Ownership Allocation
OWC Pharmaceutical secures a total of 497.5 Million outstanding shares. OWC Pharmaceutical owns 11.15 % of its outstanding shares held by insiders and 0.0 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.OWC Pharmaceutical Profitability Analysis
Net Loss for the year was (10.26 M) with profit before overhead, payroll, taxes, and interest of 0.About OWC Pharmaceutical Valuation
The pink sheet valuation mechanism determines OWC Pharmaceutical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of OWC Pharmaceutical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of OWC Pharmaceutical. We calculate exposure to OWC Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OWC Pharmaceutical's related companies.OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel. Owc Pharmaceutical is traded on OTC Exchange in the United States.
8 Steps to conduct OWC Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OWC Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OWC Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OWC Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OWC Pharmaceutical's revenue streams: Identify OWC Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OWC Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OWC Pharmaceutical's growth potential: Evaluate OWC Pharmaceutical's management, business model, and growth potential.
- Determine OWC Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OWC Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
OWC Pharmaceutical Growth Indicators
Investing in growth stocks can be very risky. If the company such as OWC Pharmaceutical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 150.2 M | |
| Retained Earnings | -27.2 M |
Additional Tools for OWC Pink Sheet Analysis
When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.